Bisphosphonates: A Treatment for Paget’s Disease
For individuals experiencing moderate to severe symptoms of Paget’s disease, bisphosphonates are commonly prescribed. These medications play a crucial role in preventing the loss of bone density and are frequently used to treat not only Paget’s disease but also other conditions that affect bone health, such as osteoporosis. In some cases, doctors may recommend an intravenous infusion of zoledronic acid, administered once every two years, for individuals whose disease is dormant but detected through diagnostic testing.
Understanding the Outlook for Individuals with Paget’s Disease
Paget’s disease, although not typically life-threatening, can have a positive prognosis when treated promptly to prevent significant bone damage and deformity. Timely diagnosis plays a crucial role in minimizing complications that may result in serious cardiovascular conditions. While medications can effectively manage symptoms, it is important to note that there is currently no known cure for Paget’s disease. Only a small percentage, less than ten percent, of individuals with Paget’s disease will develop a rare form of bone cancer called osteosarcoma. Treatment for osteosarcoma may involve chemotherapy, radiation therapy, surgery, or a combination of these options.